Key Takeaways Two Active Ingredients, Five Products GLP-1 Market Represents a Financialized Business Model Prolonged Patent Protection & Market Exclusivity Two Active Ingredients, Five Products: Semaglutide is marketed by Novo Nordisk as three separate drug products under the brand names: Ozempic (injection for diabetes, approved in 2017), Rybelsus (oral tablet for diabetes, approved in 2019), and Wegovy (injection for weight loss, approved in 2021)
Adults with Overweight & Comorbidities: Individuals with a BMI of 27 kg/m or higher who also have at least one weight-related medical condition, such as hypertension (high blood pressure), type 2 diabetes, or dyslipidemia (high cholesterol)
I felt very safe and at ease in the hands of Dr Gad, I would definitely recommend him
Lyophilized peptides must be stored at -20C before reconstitution and 28C after mixing with bacteriostatic water